Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.